Who Buys Naproxen from India — 366 Importers Behind a $133.8M Market
India's naproxen import market is served by 366 active buyers who collectively imported $133.8M across 3,414 shipments. MYLAN PHARMACEUTICALS ULC, (CANADA) leads with a 15.2% market share, followed by GLENMARK PHARMACEUTICALS INC., USA and AMNEAL PHARMACEUTICALS, LLC (KY). The top 5 buyers together control 40.2% of total import value, reflecting a moderately competitive buyer landscape.
Top Naproxen Importers — Ranked by Import Value
MYLAN PHARMACEUTICALS ULC, (CANADA) is the leading naproxen importer from India, holding a 15.2% share of the $133.8M market across 3,414 shipments from 366 buyers. The top 5 buyers — MYLAN PHARMACEUTICALS ULC, (CANADA), GLENMARK PHARMACEUTICALS INC., USA (UNITED STATES), AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES), KRKA D.D., NOVO MESTO (SLOVENIA), APL SWIFT SERVICES (MALTA) LTD., (MALTA) — collectively control 40.2% of total import value.
Top Naproxen Buyers & Importers
Ranked by import value · 366 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MYLAN PHARMACEUTICALS ULC,CANADA MYLAN NAPROXEN / ESOMEPRAZOLE MR 500 MGNAPROXEN SODIUM TABLETS USP 220MG TABSNAPROXEN ACCORD 500MG TAB | $20.3M | 5 | 15.2% |
| 2 | GLENMARK PHARMACEUTICALS INC., USAUNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELA | $11.0M | 5 | 8.2% |
| 3 | AMNEAL PHARMACEUTICALS, LLC (KY)UNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELA | $8.7M | 5 | 6.5% |
| 4 | KRKA D.D., NOVO MESTOSLOVENIA NALGESIN TABLETS 550MG (NAPROXEN SODIUMNALGESIN TABLETS 275MG (NAPROXEN SODIUMNALGESIN TABLETS 550MG NAPROXEN SODIUM | $8.7M | 5 | 6.5% |
| 5 | APL SWIFT SERVICES (MALTA) LTD.,MALTA NAPROXEN 250MG TABLETS(NAPROXEN AUROBINDNAPROXEN 250MG TABLETS(NAPROXENO GENERISNAPROXEN SODIUM TABLETS 550 MG | $5.2M | 5 | 3.9% |
| 6 | ATNAHS PHARMA UK LIMITEDSPAIN ANTALGIN 550MG NAPROXEN SODIUM TABLETS550MG PACK SIZE 4X10SANTALGIN 550MG (NAPROXEN SODIUM TABLETSANTALGIN 550MG NAPROXEN SODIUM TABLETS | $5.1M | 5 | 3.8% |
| 7 | KRKA, D.D., NOVO MESTOSLOVENIA NALGESIN TABLETS 550MG (NAPROXEN SODIUMNALGESIN TABLETS 275MG (NAPROXEN SODIUMNALGESIN TABLETS 550MG NAPROXEN SODIUM | $5.0M | 5 | 3.7% |
| 8 | DR REDDYS LABORATORIES INCUNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELAHARMLESS MEDICINE- NAPROXEN 500 MG TABLETS UNIT: 2X14 | $4.9M | 5 | 3.6% |
| 9 | KRKA D D NOVO MESTOSLOVENIA NALGESIN TABLETS 550MG (NAPROXEN SODIUMNALGESIN TABLETS 275MG (NAPROXEN SODIUMNALGESIN TABLETS 550MG NAPROXEN SODIUM | $4.6M | 5 | 3.4% |
| 10 | TIME-CAP LABS,UNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELA | $3.6M | 5 | 2.7% |
| 11 | DR. REDDYS LABORATORIES, INCUNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELA | $2.7M | 5 | 2.0% |
| 12 | GRANULES PHARMACEUTICALS INCUNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELA | $2.2M | 5 | 1.7% |
| 13 | GRANULES PHARMACEUTICALS, INC.UNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELA | $2.1M | 5 | 1.6% |
| 14 | WESTROCKUNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELA | $2.1M | 5 | 1.5% |
| 15 | GLENMARK PHARMACEUTICALS INC USAUNITED STATES NAPROXEN TAB 500MG 500NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELA | $2.0M | 5 | 1.5% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Naproxen — and from which countries?
Flow of Naproxen exports from India: each country's share and the named importers behind the numbers
Naproxen — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $56.4M through 642 shipments. This represents a market share of 42.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• GLENMARK PHARMACEUTICALS INC., USA - $11.0M (19.5% of country's total business)
• AMNEAL PHARMACEUTICALS, LLC (KY) - $8.7M (15.5% of country's total business)
• DR REDDYS LABORATORIES INC - $4.9M (8.7% of country's total business)
• TIME-CAP LABS, - $3.6M (6.4% of country's total business)
• DR. REDDYS LABORATORIES, INC - $2.7M (4.7% of country's total business)
• Rest of United States's importers - $25.5M (45.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $87.8K, indicating premium pricing strategy compared to the market average of $39.2K.
United States is a key market for Naproxen imports, representing 42.1% of total trade value.
2Canada
Canada emerges as the second largest importing country, achieving a total trade value of $28.3M through 53 shipments. This represents a market share of 21.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• MYLAN PHARMACEUTICALS ULC, - $20.3M (71.7% of country's total business)
• PHARMASCIENCE INC - $1.9M (6.7% of country's total business)
• APOTEX INC - $1.7M (5.9% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $533.7K, indicating premium pricing strategy compared to the market average of $39.2K.
Canada is a key market for Naproxen imports, representing 21.1% of total trade value.
3Slovenia
Slovenia emerges as the third largest importing country, achieving a total trade value of $21.7M through 254 shipments. This represents a market share of 16.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Slovenia has a diverse importer base, with their top importers including:
• KRKA D.D., NOVO MESTO - $8.7M (40.1% of country's total business)
• KRKA, D.D., NOVO MESTO - $5.0M (23.0% of country's total business)
• KRKA D D NOVO MESTO - $4.6M (21.1% of country's total business)
• KRKA, D,D, NOVO MESTO - $1.9M (8.5% of country's total business)
Key Insight: Slovenia demonstrates strong market positioning with an average shipment value of $85.5K, indicating premium pricing strategy compared to the market average of $39.2K.
Slovenia is a key market for Naproxen imports, representing 16.2% of total trade value.
4Malta
Malta emerges as the fourth largest importing country, achieving a total trade value of $8.6M through 291 shipments. This represents a market share of 6.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• APL SWIFT SERVICES (MALTA) LTD., - $5.2M (59.7% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $29.7K, indicating competitive pricing strategy compared to the market average of $39.2K.
Malta is a key market for Naproxen imports, representing 6.5% of total trade value.
5Spain
Spain emerges as the fifth largest importing country, achieving a total trade value of $6.0M through 156 shipments. This represents a market share of 4.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Spain has a diverse importer base, with their top importers including:
• ATNAHS PHARMA UK LIMITED - $5.1M (85.2% of country's total business)
Key Insight: Spain demonstrates strong market positioning with an average shipment value of $38.7K, indicating competitive pricing strategy compared to the market average of $39.2K.
Spain is a key market for Naproxen imports, representing 4.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Naproxen buyer market intelligence
1Buyer Segment Analysis
The 366 buyers of Naproxen imported from India can be categorized into several segments:
1. Pharmaceutical Companies: Entities such as MYLAN PHARMACEUTICALS ULC (Canada), GLENMARK PHARMACEUTICALS INC., USA (United States), and AMNEAL PHARMACEUTICALS, LLC (United States) fall into this category. These companies typically procure large quantities of Naproxen for formulation into finished pharmaceutical products. Their purchasing behavior is characterized by bulk orders and long-term contracts to ensure a steady supply chain.
2. Contract Manufacturers: Companies like KRKA D.D., NOVO MESTO (Slovenia) and DR. REDDY'S LABORATORIES INC (United States) serve as contract manufacturers. They import Naproxen to produce medications on behalf of other pharmaceutical firms. Their order patterns are project-based, aligning with the production schedules and demands of their clients.
3. Distributors and Re-exporters: Entities such as APL SWIFT SERVICES (Malta) LTD. (Malta) and ATNAHS PHARMA UK LIMITED (Spain) act as intermediaries, importing Naproxen for distribution within their domestic markets or for re-export to other regions. Their purchasing behavior is influenced by market demand fluctuations and regulatory considerations in target markets.
4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, some entities may represent large retail pharmacy chains or hospital groups that import Naproxen directly to meet the needs of their customers or patients. Their order patterns are typically consistent, reflecting steady demand in the healthcare sector.
The repeat buyer rate of 65.6% indicates a stable and reliable demand for Naproxen, suggesting strong relationships between Indian exporters and these international buyers.
Country-Specific Import Regulations
TransData Nexus Naproxen buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Naproxen are as follows:
1. United States:
2. Canada:
3. Slovenia:
4. Malta:
5. Spain:
Demand Drivers & Market Opportunity
TransData Nexus Naproxen buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Naproxen in importing countries is driven by several factors:
1. Disease Prevalence: Naproxen, a non-steroidal anti-inflammatory drug (NSAID), is widely used to treat conditions such as arthritis, musculoskeletal disorders, and acute pain. The prevalence of these conditions contributes significantly to the consistent demand for Naproxen.
2. Government Healthcare Programs: Many countries have government-sponsored healthcare programs that provide essential medicines to their populations. For instance, the inclusion of Naproxen in national essential medicines lists ensures its availability in public healthcare facilities.
3. Universal Health Coverage Expansion: Efforts to expand universal health coverage in various countries have led to increased access to essential medicines, including Naproxen. This expansion supports higher procurement volumes to meet the needs of the population.
4. WHO Essential Medicines List Procurement: Naproxen's inclusion in the World Health Organization's Essential Medicines List underscores its importance in basic healthcare. This inclusion often influences national procurement decisions, leading to sustained demand.
5. Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender processes to ensure cost-effectiveness and supply security. The repeat buyer rate of 65.6% indicates that a significant portion of Naproxen imports is managed through such structured procurement mechanisms.
With 366 buyers across 76 countries, the market for Naproxen imported from India demonstrates robust and diversified demand, presenting substantial opportunities for exporters.
Common Questions — Naproxen Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest naproxen buyer importing from India?
Based on import volume and value, MYLAN PHARMACEUTICALS ULC, (CANADA) leads with $20.3M in imports and a 15.2% market share — the highest of any single naproxen importer. GLENMARK PHARMACEUTICALS INC., USA (UNITED STATES) and AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES) are the next largest buyers.
QHow many companies buy naproxen from India?
There are 366 active naproxen buyers importing from India, with a combined market of $133.8M across 3,414 shipments to 76 countries. The top 5 buyers hold 40.2% of total import value, while the remaining 361 buyers handle the other 59.8%.
QWhich countries import the most naproxen from India?
The top importing countries for naproxen from India are United States (42.1%), Canada (21.1%), Slovenia (16.2%), Malta (6.5%), Spain (4.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of naproxen, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for naproxen from India?
The average import transaction value for naproxen from India is $39.2K, with an average unit price of $15.88 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Naproxen buyer market intelligence
1Buyer Segment Analysis
The 366 buyers of Naproxen imported from India can be categorized into several segments:
1. Pharmaceutical Companies: Entities such as MYLAN PHARMACEUTICALS ULC (Canada), GLENMARK PHARMACEUTICALS INC., USA (United States), and AMNEAL PHARMACEUTICALS, LLC (United States) fall into this category. These companies typically procure large quantities of Naproxen for formulation into finished pharmaceutical products. Their purchasing behavior is characterized by bulk orders and long-term contracts to ensure a steady supply chain.
2. Contract Manufacturers: Companies like KRKA D.D., NOVO MESTO (Slovenia) and DR. REDDY'S LABORATORIES INC (United States) serve as contract manufacturers. They import Naproxen to produce medications on behalf of other pharmaceutical firms. Their order patterns are project-based, aligning with the production schedules and demands of their clients.
3. Distributors and Re-exporters: Entities such as APL SWIFT SERVICES (Malta) LTD. (Malta) and ATNAHS PHARMA UK LIMITED (Spain) act as intermediaries, importing Naproxen for distribution within their domestic markets or for re-export to other regions. Their purchasing behavior is influenced by market demand fluctuations and regulatory considerations in target markets.
4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, some entities may represent large retail pharmacy chains or hospital groups that import Naproxen directly to meet the needs of their customers or patients. Their order patterns are typically consistent, reflecting steady demand in the healthcare sector.
The repeat buyer rate of 65.6% indicates a stable and reliable demand for Naproxen, suggesting strong relationships between Indian exporters and these international buyers.
Country-Specific Import Regulations
TransData Nexus Naproxen buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Naproxen are as follows:
1. United States:
2. Canada:
3. Slovenia:
4. Malta:
5. Spain:
Demand Drivers & Market Opportunity
TransData Nexus Naproxen buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Naproxen in importing countries is driven by several factors:
1. Disease Prevalence: Naproxen, a non-steroidal anti-inflammatory drug (NSAID), is widely used to treat conditions such as arthritis, musculoskeletal disorders, and acute pain. The prevalence of these conditions contributes significantly to the consistent demand for Naproxen.
2. Government Healthcare Programs: Many countries have government-sponsored healthcare programs that provide essential medicines to their populations. For instance, the inclusion of Naproxen in national essential medicines lists ensures its availability in public healthcare facilities.
3. Universal Health Coverage Expansion: Efforts to expand universal health coverage in various countries have led to increased access to essential medicines, including Naproxen. This expansion supports higher procurement volumes to meet the needs of the population.
4. WHO Essential Medicines List Procurement: Naproxen's inclusion in the World Health Organization's Essential Medicines List underscores its importance in basic healthcare. This inclusion often influences national procurement decisions, leading to sustained demand.
5. Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender processes to ensure cost-effectiveness and supply security. The repeat buyer rate of 65.6% indicates that a significant portion of Naproxen imports is managed through such structured procurement mechanisms.
With 366 buyers across 76 countries, the market for Naproxen imported from India demonstrates robust and diversified demand, presenting substantial opportunities for exporters.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 366 global importers of Naproxen identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,414 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 76 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,414 Verified Shipments
366 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists